Eris Lifesciences appoints Vineet Varma as Non-Executive Independent Director

Eris Lifesciences Limited has appointed Vineet Varma as a Non-Executive Independent Director, effective March 14, 2026, for a five-year term, subject to the approval of the members. The appointment adds an additional director to the board, reinforcing Eris Lifesciences’ governance framework with independent oversight on strategic decisions and risk management.

Varma arrives with a rich background as a professional banker, boasting more than 25 years in wholesale banking across renowned international and domestic banks. His expertise spans transaction banking, trade and cash management, trade and supply chain financing, global markets, treasury and corporate banking. He has helped build financial institutions businesses at FAB, NBAD and ABN Amro and has served on Client Advisory Boards at Citibank and Bank of America Merrill Lynch (BoAML). He is an alumnus of London Business School and Shriram College of Commerce.

According to the accompanying information, Varma is not related to any director of the company and is not debarred from holding the office of director by SEBI or other authorities. The board’s move signals Eris Lifesciences’ continued emphasis on independent oversight and governance, leveraging Varma’s depth of experience in financial services to inform strategic choices in a dynamic market environment.